Primary Biliary Cholangitis Clinical Trial Pipeline Pharmaceutical companies are advancing the Primary Biliary Cholangitis treatment pipeli ...

By Tarun Sai Lomte A four-week treatment with oral vancomycin led to clinical remission in PSC-IBD patients, accompanied by ...

Follow-up of patients is life-long and must address treatment of the disease and management of associated symptoms. autoimmune liver disease care pathway guidelines ursodeoxycholic acid obeticholic ...

Livdelzi (seladelpar) is a medicine that can treat primary biliary cholangitis (PBC) by reducing the amount of bile in your body. It does this by signaling the body to stop making bile acid.

Medically reviewed by Jay N. Yepuri, MD Primary sclerosing cholangitis (PSC) is a progressive scarring of the liver's bile ...

With Gilead Sciences' long-acting lenacapavir unlocking a reinvigorated focus on the pre-exposure prophylaxis (PrEP) market ...

This highlights the need for tailored approaches in treatment to optimize outcomes. Acute Cholangitis: An infection of the bile duct system that can lead to serious complications if not treated ...

An antibiotic used to treat infective diarrhoea may be an effective drug for a type of inflammatory bowel disease, according ...

Overall, 23 PSC-IBD cases (32%) underwent OLT for treatment of PSC. Of these, six (26% ... In this referral centre based study, inflammatory bowel disease associated with primary sclerosing ...

Full-year sales reached $26.8 billion, driven by robust performance across HIV, oncology, and liver disease portfolios. HIV sales grew 8% year-over-year to $19.6 billion in 2024, exceeding ...

Canaccord Genuity has downgraded Pliant (PLRX) to hold following news that the company has paused a clinical trial for its ...